Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · IEX Real-Time Price · USD
8.37
-0.54 (-6.06%)
Jan 27, 2022 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019
Selling, General & Admin
5.573.61
Research & Development
21.18.22
Operating Expenses
26.6711.82
Operating Income
-26.67-11.82
Other Expense / Income
-0.14-6.72
Pretax Income
-26.52-5.1
Net Income
-26.52-5.1
Net Income Common
-26.52-5.1
Shares Outstanding (Basic)
87
Shares Outstanding (Diluted)
87
Shares Change
18.45%-
EPS (Basic)
-3.32-0.76
EPS (Diluted)
-3.32-0.76
Free Cash Flow Per Share
-3.49-1.69
EBITDA
-26.2-5
EBIT
-26.52-5.1
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).